Physician profile
Leila Mady
NPI 1215355078
$3,296.31
in general payments reported to CMS, 2019-2025
8 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $142 · 2021: $272 · 2022: $294 · 2023: $914 · 2024: $1,534 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,463 · Food and Beverage: $1,125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,462.50 |
| Food and Beverage | $1,125.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atos Medical INC | $1,462.50 | 2023-2024 | Trachphone (30 Pcs), Provox Life Home Hme |
| Stryker Corporation | $824.67 | 2020-2024 | Na, Patient-Fitted Tmj Reconstructive Prosthesis System, Core |
| Baxter Healthcare | $288.36 | 2023-2025 | Tisseel |
| Aroa Biosurgery Incorporated | $249.63 | 2024 | |
| Depuy Synthes Sales INC. | $178.47 | 2022-2024 | Trumatch |
| Ambu INC. | $114.22 | 2022 | |
| Acera Surgical, INC. | $108.20 | 2022 | |
| Ethicon US, LLC | $70.26 | 2023-2024 | Echelon Flex, Vistaseal, Harmonic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leila Mady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.